VanEck Associates’s Braskem BAK Stock Holding History
Bought
Maintained
Sold
Other funds holding BAK
BFM
XSC
LCM
VCM
VanEck Associates's BAK Position: Q1 2026 in Review
VanEck Associates increased its Braskem (BAK) stake by 7.3% in Q1 2026, buying an estimated $7.85K and bringing the position to 30,609 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.
VanEck Associates first reported a position in BAK in Q3 2025 and has held it in 3 quarters since. The position peaked at $117K in Q3 2025. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.
- VanEck Associates held 30,609 shares of Braskem worth $112K as of Q1 2026.
- VanEck Associates bought 2,072 Braskem shares in Q1 2026, an estimated $7.85K.
- Braskem made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #1301 holding.
- VanEck Associates first reported a position in Braskem in Q3 2025 and has held it in 3 quarters since.
- VanEck Associates's Braskem position peaked at $117K in Q3 2025.
- 64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.